Jane Street Group, LLC Inovio Pharmaceuticals, Inc. Call Options Transaction History

Jane Street Group, LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 17, 2022	SELL	$2.97 - $5.2 $996,435 - $1.74 Million	-335,500 Reduced 81.57%	75,800 $272,000
Q4 2021 Feb 15, 2022	SELL	$4.99 - $7.46 $375,248 - $560,992	-75,200 Reduced 15.46%	411,300 $2.05 Million
Q3 2021 Nov 16, 2021	SELL	$7.16 - $9.69 $603,588 - $816,867	-84,300 Reduced 14.77%	486,500 $3.48 Million
Q2 2021 Aug 16, 2021	SELL	$6.23 - $10.03 $1.08 Million - $1.74 Million	-173,400 Reduced 23.3%	570,800 $5.29 Million
Q1 2021 May 18, 2021	BUY	$8.81 - $16.96 $1.24 Million - $2.38 Million	140,300 Added 23.23%	744,200 $6.91 Million
Q4 2020 Feb 17, 2021	SELL	$8.5 - $12.85 $19.4 Million - $29.4 Million	-2,287,400 Reduced 79.11%	603,900 $5.35 Million
Q3 2020 Nov 17, 2020	SELL	$9.57 - $27.05 $6.17 Million - $17.4 Million	-644,300 Reduced 18.22%	2,891,300 $33.5 Million
Q2 2020 Aug 17, 2020	BUY	$7.14 - $31.69 $17.3 Million - $76.6 Million	2,417,500 Added 216.22%	3,535,600 $95.3 Million
Q1 2020 May 15, 2020	BUY	$2.98 - $14.09 $3.3 Million - $15.6 Million	1,107,700 Added 10650.96%	1,118,100 $8.32 Million
Q3 2017 Nov 14, 2017	BUY	$5.36 - $6.37 $55,744 - $66,248	10,400	10,400 $66,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $459M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.